Related references
Note: Only part of the references are listed.Revealing new landscape of cardiovascular disease through circular RNA-miRNA-mRNA axis
Qiang Su et al.
GENOMICS (2020)
Targeting CDK2 in cancer: challenges and opportunities for therapy
Solomon Tadesse et al.
DRUG DISCOVERY TODAY (2020)
MiRNA-339-5p suppresses the malignant development of gastric cancer via targeting ALKBH1
Chenchen Wang et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2020)
CD40-miRNA axis controls prospective cell fate determinants during B cell differentiation
Satyajeet Salunkhe et al.
MOLECULAR IMMUNOLOGY (2020)
Arsenic-induced changes in miRNA expression in cancer and other diseases
Ana P. Ferragut Cardoso et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2020)
Propofol inhibits pancreatic cancer progress under hypoxia via ADAM8
Yutong Gao et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2019)
miR-340-FHL2 axis inhibits cell growth and metastasis in ovarian cancer
Zheng Huang et al.
CELL DEATH & DISEASE (2019)
MiRNA-217 accelerates the proliferation and migration of bladder cancer via inhibiting KMT2D
Guoliang Hou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
miRNA-29b Inhibits Prostate Tumor Growth and Induces Apoptosis by Increasing Bim Expression
Subhayan Sur et al.
CELLS (2019)
Propofol induces apoptosis of breast cancer cells by downregulation of miR-24 signal pathway
Benxia Yu et al.
CANCER BIOMARKERS (2018)
NPTX1 inhibits colon cancer cell proliferation through down-regulating cyclin A2 and CDK2 expression
Xiaofeng Peng et al.
CELL BIOLOGY INTERNATIONAL (2018)
MiR-340 suppresses the metastasis by targeting EphA3 in cervical cancer
Hemei Xiao et al.
CELL BIOLOGY INTERNATIONAL (2018)
Effects of propofol on cancer development and chemotherapy: Potential mechanisms
Sufang Jiang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Identification of CDK2 as a novel target in treatment of prostate cancer
Xifeng Yin et al.
FUTURE ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
被撤回的出版物: Propofol inhibits proliferation, migration and invasion of gastric cancer cells by up-regulating microRNA-195 (Retracted article. See vol. 202, pg. 707, 2022)
Wenyu Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Propofol suppresses growth, migration and invasion of A549 cells by down-regulation of miR-372
Hai Sun et al.
BMC CANCER (2018)
Propofol attenuates pancreatic cancer malignant potential via inhibition of NMDA receptor
Xiangyuan Chen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
J. Alfred Witjes et al.
EUROPEAN UROLOGY (2017)
Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
Roger Chou et al.
JOURNAL OF UROLOGY (2017)
Bladder cancer: Present and future
Roberto Hugo Martinez Rodriguez et al.
MEDICINA CLINICA (2017)
Propofol inhibits hepatocellular carcinoma growth and invasion through the HMGA2-mediated Wnt/β-catenin pathway
Wei Ou et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
miRNA-223 suppresses FOX01 and functions as a potential tumor marker in breast cancer
Y-T. Wei et al.
CELLULAR AND MOLECULAR BIOLOGY (2017)
Propofol inhibits lung cancer cell viability and induces cell apoptosis by upregulating microRNA-486 expression
N. Yang et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2017)
Propofol enhances the cisplatin-induced apoptosis on cervical cancer cells via EGFR/JAK2/STAT3 pathway
Haoran Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
MicroRNA-340 inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting JAK1
Jianyong Yuan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer
Maria Teresa Herrera-Abreu et al.
CANCER RESEARCH (2016)
MicroRNA-340 Induces Apoptosis and Inhibits Metastasis of Ovarian Cancer Cells by Inactivation of NF-κB1
Peiquan Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Propofol: A Review of its Role in Pediatric Anesthesia and Sedation
Vidya Chidambaran et al.
CNS DRUGS (2015)
Propofol suppresses proliferation and invasion of pancreatic cancer cells by upregulating microRNA-133a expression
Z. T. Wang et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Different micro-RNA expression profiles distinguish subtypes of neuroendocrine tumors of the lung: results of a profiling study
Fabian Dominik Mairinger et al.
MODERN PATHOLOGY (2014)
GABA-receptor agonist, propofol inhibits invasion of colon carcinoma cells
Yufeng Miao et al.
BIOMEDICINE & PHARMACOTHERAPY (2010)
Comparison of two drug combinations in total intravenous anesthesia: Propofol-ketamine and propofol-fentanyl
Sukhminder Jit Singh Bajwa et al.
SAUDI JOURNAL OF ANAESTHESIA (2010)
Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells
RA Siddiqui et al.
BREAST CANCER RESEARCH (2005)
Share Paper
